SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal
The deal provides SanegeneBio with an upfront payment of $200m.
Drug Development
Aquestive receives FDA CRL for Anaphylm allergic reaction treatment
CHMP grants positive opinion for J&J’s Akeega use
CIRM unveils RAPID funding programme for rare diseases
IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation
Repertoire and Lilly join hands on autoimmune disease therapies
Sensorion announces $71.9m reserved offering to expand gene therapy pipeline
FDA grants breakthrough status to Biogen’s litifilimab for CLE
